IV 

115TH CONGRESS 

2D SESSION H. RES. 1062 

Supporting the goals to protect United States military personnel from malaria. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 12, 2018 

Mr. PANETTA (for himself and Mr. MAST) submitted the following resolution; 

which was referred to the Committee on Foreign Affairs, and in addition 

to the Committees on Armed Services, and Energy and Commerce, for 

a period to be subsequently determined by the Speaker, in each case for 

consideration of such provisions as fall within the jurisdiction of the committee concerned 

RESOLUTION 

Supporting the goals to protect United States military 

personnel from malaria. 

Whereas fighting malaria is in the national interest of the 

United States; 

Whereas reducing the incidence of malaria protects United 

States servicemembers deployed to malaria-endemic regions; 

Whereas the ‘‘World malaria report 2017’’ by the World 

Health Organization states that, in 2016, approximately 

445,000 people died of malaria; 


pbinns on DSK79D2C42PROD with BILLS
2 

•HRES 1062 IH 

Whereas, in 2016, 91 countries and areas had ongoing malaria transmissions, including areas of Africa and the 

Middle East; 

Whereas the Department of Defense reports that a total of 

60 servicemembers were diagnosed with malaria in 2016, 

the highest number since 2011; 

Whereas incidents of malaria were diagnosed at or reported 

from 19 different medical facilities in the United States, 

Afghanistan, Qatar, Germany, Djibouti, Japan, and 

South Korea in 2017; 

Whereas the Department of Defense recognizes malaria as 

the number one infectious disease threat to United States 

military forces; 

Whereas United States support for efforts to fight malaria is 

in the foreign policy and humanitarian interests of the 

United States and highlights the values of the people of 

the United States through the work of governmental, 

nongovernmental, and faith-based organizations of the 

United States that are on the frontlines of the malaria 

battle globally; 

Whereas United States support for efforts to fight malaria 

and other infectious diseases advance the United States 

National Security Strategy, and is a key tool to enhance 

operational readiness, interoperability, and security cooperation, protecting Americans at home and abroad; 

Whereas the United States Government has played a leading 

role in the recent progress made toward reducing the 

global burden of malaria and other infectious diseases, 

particularly through bilateral, multilateral, international, 

and civil society partners; 


pbinns on DSK79D2C42PROD with BILLS
3 

•HRES 1062 IH 

Whereas, since 1893, the Walter Reed Army Institute of Research (WRAIR) has played a leadership role protecting 

United States servicemembers from the world’s most pervasive infectious diseases, including malaria, HIV/AIDS, 

Ebola, and dengue; 

Whereas WRAIR Center for Infectious Disease Research has 

been responsible for developing critical Food and Drug 

Administration-approved medicines, vaccines, drugs, and 

other interventions used to prevent malaria, Japanese encephalitis, hepatitis A, adenovirus, and other infectious 

diseases in deployed servicemembers; 

Whereas the WRAIR Malaria Vaccine and Experimental 

Therapeutics Branches have emerged as the Department 

of Defense’s premier effort to develop vaccines and drugs 

to protect the warfighter from malaria and other infectious diseases and military health threats; 

Whereas WRAIR continues to play a leadership role in the 

research and development of lifesaving medicines including the recently approved tafenoquine, a radical cure and 

prophylaxis that protects the warfighter from P vivax relapse, a condition that causes approximately 8.5 million 

clinical infections per year worldwide; 

Whereas WRAIR leads the fight against drug-resistant 

strains of malaria, developing new treatments that have 

revolutionized malaria prevention efforts; 

Whereas WRAIR’s international network of laboratories supports medical diplomacy and fosters United States-host 

nation collaborations in biomedical research; and 

Whereas WRAIR’s unique expertise, capabilities, and resources have led to historic clinical trials, testing vaccines 


pbinns on DSK79D2C42PROD with BILLS
4 

•HRES 1062 IH 

to prevent the spread of HIV/AIDS, zika, and malaria: 

Now, therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) supports the goals of researching new inter3 ventions to prevent and treat malaria, as it is in the 

4 national security, foreign affairs, political, and hu5 manitarian interest of the United States; 

6 (2) encourages continued leadership by the 

7 United States through programs such as the Walter 

8 Reed Army Institute of Research to ensure that the 

9 health of the Force is not jeopardized by vector10 borne diseases; and 

11 (3) supports sustained or enhanced efforts so 

12 that once eliminated in a country, malaria does not 

13 return. 

Æ 


pbinns on DSK79D2C42PROD with BILLS